ENDRA Life Sciences (NDRA) Stock Price, Quote, News & History

Comments

ENDRA Life Sciences Inc (NDRA) Stock Price, Quote, News & History

NDRANASDAQ

Trade with Public

$4.65

N/A

At close: Mar 31, 5:00 PM EST

$4.65

N/A

Pre-Market: 4:00 AM EST

Earnings: Q4 2025 Earnings were released on Tue Mar 31st, after the market close

OverviewNews Earnings Analyst Ratings Insider Trades Short Interest Stock Report

Key Statistics

Open

-

Close

$4.65

Volume / Avg.

0 / 109.81K

Day Range

- - -

52 Wk Range

2.90 - 11.96

Market Cap

$5.42M

P/E Ratio

0.24

Dividend Yield

-

Exchange

NASDAQ

RSI

66

Short Interest

4.92%

Days to Cover

1

Recent ENDRA Life Sciences Inc News

ENDRA Life Sciences Gains Momentum With Crypto-Focused Treasury Plan

ENDRA Life Sciences Inc. (NASDAQ: NDRA) announced $4.9M in funding to launch a digital asset treasury strategy.

Akanksha Bakshi

Why ENDRA Life Sciences (NDRA) Stock Is Up 140%

ENDRA Life Sciences shares are trading higher by 147% Tuesday. The company announced the activation of a post market clinical study of the TAEUS liver system.

Henry Khederian

Why Levi Strauss Shares Are Trading Lower By Over 10%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-5.09M

Investing Cash Flow (TTM)

-17.28K

Financing Cash Flow (TTM)

1.15M

Free Cash Flow (TTM)

-5.10M

Capital Expenditure (TTM)

-17.28K

Net Change in Cash (TTM)

-3.95M

Analyst Trends and Forecast

1

Dec 25

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$5.16M

PE Ratio (TTM)

0.24

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

31.65

Earnings Yield % (TTM)

419.78%

Earnings Yield % (FWD)

-99.35%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.15

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

$0

Total Cash

$794.04K

Debt to Equity

3.07

Issuance of Debt (TTM)

$0

Repayment of Debt (TTM)

$0

Key Statistics

Open

-

Close

$4.65

Volume / Avg.

0 / 109.81K

Day Range

- - -

52 Wk Range

2.90 - 11.96

Market Cap

$5.42M

P/E Ratio

0.24

Dividend Yield

-

Exchange

NASDAQ

RSI

66

Short Interest

4.92%

Days to Cover

1

About

Sector

Health Care

Industry

Health Care Equipment & Supplies

ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI at the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultras...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy ENDRA Life Sciences (NDRA) stock?

A

You can purchase shares of ENDRA Life Sciences (NASDAQ:NDRA) through any online brokerage.

View our list of the best stock brokerages

Q

Who are ENDRA Life Sciences (NDRA) competitors?

A

Other companies in ENDRA Life Sciences’s space includes: Catheter Precision Inc (AMEX:VTAK), Nexalin Technology Inc (NASDAQ:NXL), Bluejay Diagnostics Inc (NASDAQ:BJDX), Autonomix Medical Inc (NASDAQ:AMIX) and Tivic Health Systems Inc (NASDAQ:TIVC).

Q

What is the forecast, or price target, for ENDRA Life Sciences (NDRA) stock?

A

ENDRA Life Sciences has a consensus price target of $30.00.

Q

What is the current price for ENDRA Life Sciences (NDRA)?

A

The stock price for ENDRA Life Sciences (NASDAQ: NDRA) is $4.65 last updated April 1, 2026 at 4:17 PM EDT.

Q

Does ENDRA Life Sciences (NDRA) pay a dividend?

A

There are no upcoming dividends for ENDRA Life Sciences.

Q

When is ENDRA Life Sciences (NASDAQ:NDRA) reporting earnings?

A

ENDRA Life Sciences does not have any upcoming earnings scheduled.

Q

Is ENDRA Life Sciences (NDRA) going to split?

A

There is no upcoming split for ENDRA Life Sciences.

Q

What sector and industry does ENDRA Life Sciences (NDRA) operate in?

A

ENDRA Life Sciences is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.

People Also Watch

Catheter Precision Inc

AMEX:VTAK

$0.92

-1.96%

Nexalin Technology Inc

NASDAQ:NXL

$0.36

0.14%

Bluejay Diagnostics Inc

NASDAQ:BJDX

$1.82

-3.85%

Autonomix Medical Inc

NASDAQ:AMIX

$0.40

-0.60%

Tivic Health Systems Inc

NASDAQ:TIVC

$1.00

-1.00%

SeaStar Medical Holding Corp

Intelligent Bio Solutions Inc

NASDAQ:INBS

$3.50

10.86%

Key Statistics

Open

-

Close

$4.65

Volume / Avg.

0 / 109.81K

Day Range

- - -

52 Wk Range

2.90 - 11.96

Market Cap

$5.42M

P/E Ratio

0.24

Dividend Yield

-

Exchange

NASDAQ

RSI

66

Short Interest

4.92%

Days to Cover

1

Recent ENDRA Life Sciences Inc News

ENDRA Life Sciences Gains Momentum With Crypto-Focused Treasury Plan

ENDRA Life Sciences Inc. (NASDAQ: NDRA) announced $4.9M in funding to launch a digital asset treasury strategy.

Akanksha Bakshi

Why ENDRA Life Sciences (NDRA) Stock Is Up 140%

ENDRA Life Sciences shares are trading higher by 147% Tuesday. The company announced the activation of a post market clinical study of the TAEUS liver system.

Henry Khederian

Why Levi Strauss Shares Are Trading Lower By Over 10%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-5.09M

Investing Cash Flow (TTM)

-17.28K

Financing Cash Flow (TTM)

1.15M

Free Cash Flow (TTM)

-5.10M

Capital Expenditure (TTM)

-17.28K

Net Change in Cash (TTM)

-3.95M

Analyst Trends and Forecast

1

Dec 25

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$5.16M

PE Ratio (TTM)

0.24

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

31.65

Earnings Yield % (TTM)

419.78%

Earnings Yield % (FWD)

-99.35%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.15

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

$0

Total Cash

$794.04K

Debt to Equity

3.07

Issuance of Debt (TTM)

$0

Repayment of Debt (TTM)

$0

Key Statistics

Open

-

Close

$4.65

Volume / Avg.

0 / 109.81K

Day Range

- - -

52 Wk Range

2.90 - 11.96

Market Cap

$5.42M

P/E Ratio

0.24

Dividend Yield

-

Exchange

NASDAQ

RSI

66

Short Interest

4.92%

Days to Cover

1

About

Sector

Health Care

Industry

Health Care Equipment & Supplies

ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI at the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultras...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry